Controlling infectious diseases requires prevention, detection, and rapid response. Are your diagnostic tests ready to meet the challenge? Medix Biochemica supplies high-performance antibodies and antigens for infectious disease testing. We want to support global health efforts and expand access to underserved diseases and regions. Join us in strengthening global diagnostic capabilities. Let’s talk! https://lnkd.in/dExWN2SZ #InfectiousDiseases #IVD #Diagnostics
Medix Biochemica
Biotechnology Research
Independent, international, and industry-leading critical raw materials partner to the global IVD community
About us
With Finnish roots and rapidly growing global branches, Medix Biochemica is a leading supplier of critical raw materials to the in vitro diagnostics (IVD) industry worldwide. We develop, produce and supply high-quality antibodies, antigens, and other critical raw material products to our IVD partners all around the world, enabling the delivery of accurate IVD tests to billions of patients worldwide. Our expertise covers everything from immuno- and molecular diagnostic reagents to biospecimens and custom services. With the most comprehensive raw material portfolio in the IVD world, and a team made up of the best minds in the business, we’re ready to shorten our customers’ time to market and build quality into every one of their tests. Across disciplines and disease areas, whatever you need, chances are we IVDo that. Visit our website today⬇️
- Website
-
https://eu1.hubs.ly/H024cr-0
External link for Medix Biochemica
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- Espoo
- Type
- Privately Held
- Founded
- 1985
- Specialties
- Diagnostics, Monoclonal antibodies, Antigens, IVD, immunodiagnostics, R&D, Contract manufacturing, in vitro diagnostics, Biotechnology, reagents, assay development, Recombinant antibodies, molecular diagnostic reagents, and contract manufacturing
Locations
Employees at Medix Biochemica
Updates
-
Celebrating 40 years of growth & innovation! As part of our journey to becoming the first-choice, independent raw material partner for the IVD industry, Medix Biochemica strengthened our molecular diagnostics offerings with the acquisition of myPOLS Biotec in 2022. With myPOLS’ expertise in DNA and RNA polymerase engineering, we strengthened our molecular diagnostics reagent portfolio-offering customers cutting-edge solutions for assay development, direct-from-sample testing, and custom reagent design. This milestone reflects our commitment to scientific excellence, customer success, and global expansion. Here’s to 40 years of innovation -and many more to come! Read our story and subscribe to stay connected! Read more: https://lnkd.in/d3wUjwSt #MedixBiochemica40years #CompanyGrowth #Milestone #Anniversary #WeIVDoThat
-
We’re live at the ESCMID - European Society of Clinical Microbiology and Infectious Diseases 2025 annual meeting in Vienna, Austria! Our team is on-site and ready to dive into conversations about our molecular diagnostics capabilities - especially personalized polymerases - and our wide range of infectious disease testing raw materials. Come see us at Booth I21 – let’s explore how we can build a trusted partnership together! We’re excited to connect – see you soon! #ESCMID2025 #MDx #MedixBiocheimca #InfectiousDiseases
-
-
We are excited to share an inspiring story about our Technology Manager, Laura Kolsi, PhD featured in a recent article by the University of Helsinki. Laura's journey from her doctoral thesis to her current role at Medix Biochemica showcases her tremendous growth and dedication to advancing scientific research. In the article, Laura discusses how her skills developed during her doctoral studies, focusing on the anti-cancer activity of synthetic natural product derivatives. Today, she oversees the production of synthetic small-molecule antigens for drug testing, demonstrating the real-world impact of her research. 🔗 Read her inspiring story here: https://lnkd.in/etvjvyNh #MeetTheTeam #OneMedix #LifeAtMedixBiochemica #CareerJourney
-
ESCMID 2025 is here! Our team is in Austria and prepared to delve into our extensive range of capabilities and offerings in infectious disease and molecular diagnostics raw materials. Join us at booth I21 to take the initial strides toward establishing a trusted partnership. We look forward to meeting you there! Not attending? Feel free to contact us here: https://lnkd.in/d4tTj638 #MedixBiochemica #ESCMID2025
-
-
Celebrating 40 years of innovation! Medix Biochemica is proud to kick off our 40th anniversary celebration! Since 1985, we've grown from a visionary startup in Finland to a global leader in IVD raw materials – enabling over 1 million diagnostic tests daily. Over the coming months, we'll share insights, stories, and fun facts from our teams around the world. Because at the heart of our success is our people. Join us as we reflect on our journey and look ahead to the future of diagnostics. Read our story and subscribe to stay connected! Read more: https://lnkd.in/d58hr8uY #MedixBiochemica40years #CompanyGrowth #Milestone #Anniversary #WeIVDoThat
-
Traveling exposes you to new experiences - and new infectious diseases. That's why diagnostic capabilities must be everywhere. Medix Biochemica delivers bulk quantities of critical raw materials with quick turnaround times, enabling faster response to infectious disease threats. Let’s work together to expand testing where it’s needed most. Request a sample today! 👉 https://lnkd.in/dqH-8JES #WeIVDoThat #DiseasePreparedness #Inectious #GlobalHealth
-
-
We eagerly anticipate exhibiting and meeting our customers at ESCMID 2025 in Vienna, Austria! Visit us at booth I21 from April 11 - 15 to discuss your infectious disease or molecular diagnostic raw material needs. We look forward to seeing you there! #MedixBiochemica #ESCMID2025
-
-
Global health affects us all. Whether at home or traveling, reliable diagnostics are crucial for early detection and outbreak response. Medix Biochemica provides high-quality raw materials for rapid infectious disease tests, supporting global health efforts. Click to request samples! https://lnkd.in/dr9XQjDV Or, contact us to learn how we can help you develop robust diagnostic solutions: https://lnkd.in/dgXdrXWJ #InfectiousDisease #GlobalHealth #Diagnostics #IVD
-
-
One size doesn’t fit all in MDx assay development – and it shouldn’t have to. Our custom reagent solutions are designed to match your specific assay needs, whether you’re working with qPCR, NGS, CRISPR, or isothermal amplification. From optimizing sensitivity to streamlining workflows, we help you achieve faster, more reliable results. Let’s collaborate to create a solution that works for you. Set up a free consultation with our team today! (https://lnkd.in/d5gqjCEM #MDx #customservices #MedixBiochemica
-